Cargando…
Temporary Suppression of Cardiac Ganglionated Plexi Leads to Long‐Term Suppression of Atrial Fibrillation: Evidence of Early Autonomic Intervention to Break the Vicious Cycle of “AF Begets AF”
BACKGROUND: Botulinum toxin (BTX), temporarily suppressing cholinergic transmission (<3 weeks), has been reported to suppress atrial fibrillation (AF) for ≥1 year. We aimed to investigate the mechanism underlying long‐term suppression of AF caused by injecting BTX into major atrial ganglionated p...
Autores principales: | Lo, Li‐Wei, Chang, Hung‐Yu, Scherlag, Benjamin J., Lin, Yenn‐Jiang, Chou, Yu‐Hui, Lin, Wei‐Lun, Chen, Shih‐Ann, Po, Sunny S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5015371/ https://www.ncbi.nlm.nih.gov/pubmed/27381759 http://dx.doi.org/10.1161/JAHA.116.003309 |
Ejemplares similares
-
Ganglionated Plexi Ablation Suppresses Chronic Obstructive Sleep Apnea-Related Atrial Fibrillation by Inhibiting Cardiac Autonomic Hyperactivation
por: Zhang, Ling, et al.
Publicado: (2021) -
Fractionation Mapping of the Ganglionated Plexi for Cardioneuroablation
por: John, Leah A., et al.
Publicado: (2021) -
Ganglionated Plexi Ablation for the Treatment of Atrial Fibrillation
por: Avazzadeh, Sahar, et al.
Publicado: (2020) -
Small-molecule inhibitor of AF9/ENL-DOT1L/AF4/AFF4 interactions suppresses malignant gene expression and tumor growth
por: Wu, Fangrui, et al.
Publicado: (2021) -
AFS Monitoring: The CERN AFS Console
por: Wiebalck, Arne
Publicado: (2008)